首页 > 最新文献

Annals of vascular diseases最新文献

英文 中文
Intraoperative Blood Flow Evaluation Using Indocyanine Green Fluorescence Angiography for the Surgical Reconstruction of a Hilar Renal Artery Aneurysm. 利用吲哚青绿荧光血管造影术评估肝肾动脉瘤手术重建的术中血流情况
IF 0.6 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-06-25 Epub Date: 2024-04-02 DOI: 10.3400/avd.cr.23-00085
Hiromasa Nakamura, Yujiro Miura, Atsuyuki Mitsuishi, Ren Saito, Takashi Karashima, Satoshi Fukata, Hideo Fukuhara

Surgical reconstruction is one of the standard treatments for renal artery aneurysm. However, its intraoperative evaluation is sometimes difficult depending on the operative field, aneurysm morphology, and peripheral blood vessel distribution. This case demonstrated that after renal artery reconstruction, indocyanine green fluorescence angiography is used to evaluate the results of repairing. This method is useful in visceral aneurysm evaluation not only for assessing reconstructed blood flow but also for confirming tissue perfusion of the renal parenchyma.

手术重建是治疗肾动脉瘤的标准方法之一。然而,由于手术视野、动脉瘤形态和外周血管分布的不同,术中评估有时比较困难。本病例表明,肾动脉重建后,可使用吲哚青绿荧光血管造影术来评估修复效果。这种方法在内脏动脉瘤评估中非常有用,不仅能评估重建后的血流,还能确认肾实质的组织灌注情况。
{"title":"Intraoperative Blood Flow Evaluation Using Indocyanine Green Fluorescence Angiography for the Surgical Reconstruction of a Hilar Renal Artery Aneurysm.","authors":"Hiromasa Nakamura, Yujiro Miura, Atsuyuki Mitsuishi, Ren Saito, Takashi Karashima, Satoshi Fukata, Hideo Fukuhara","doi":"10.3400/avd.cr.23-00085","DOIUrl":"10.3400/avd.cr.23-00085","url":null,"abstract":"<p><p>Surgical reconstruction is one of the standard treatments for renal artery aneurysm. However, its intraoperative evaluation is sometimes difficult depending on the operative field, aneurysm morphology, and peripheral blood vessel distribution. This case demonstrated that after renal artery reconstruction, indocyanine green fluorescence angiography is used to evaluate the results of repairing. This method is useful in visceral aneurysm evaluation not only for assessing reconstructed blood flow but also for confirming tissue perfusion of the renal parenchyma.</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"17 2","pages":"192-196"},"PeriodicalIF":0.6,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11196172/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141452723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of a New Adjustable Compression Garment (McBoooon) Made of Non-Stretch Self-Adhesive Fabric. 开发由无弹力自粘布料制成的新型可调节压力服装(McBoooon)。
IF 0.6 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-06-25 Epub Date: 2024-04-18 DOI: 10.3400/avd.oa.23-00107
Yasushi Shiraishi, Naomi Kinoto, Atsuko Miyoshi, Kyoko Ishii, Mika Ogawa

Objectives: To assess the physical features and compression characteristics of a newly developed adjustable compression garment, McBoooon (Mc). Methods: Twelve healthy volunteers were recruited to assess the compression characteristics. The interface pressure (IP) was continuously measured to calculate the static (SSI) and dynamic stiffness indices (DSI). Additionally, the peak flow velocity (PV) of the popliteal vein during ankle dorsiflexion was measured using ultrasonography. Each parameter was compared between ASHIKA stockings (AS), Mc applied at the same resting pressure as AS (Mc1), and Mc applied at a resting pressure approximately twice that of Mc1 (Mc2). Results: SSI and DSI were significantly different, increasing in the order AS < Mc1 < Mc2 (p <0.01). Although the PV was significantly higher in the compression group than in the control group (p <0.05), no significant differences were found among the three groups. Conclusion: The physical features and compression characteristics of Mc were clarified. The high stiffness of this garment improves the adherence to compression therapy and contributes to the treatment of chronic venous insufficiency.

目的评估新开发的可调节压力服 McBoooon (Mc) 的物理特性和压力特征。方法:招募 12 名健康志愿者,对其压力特性进行评估:招募 12 名健康志愿者来评估压力特性。连续测量界面压力(IP)以计算静态(SSI)和动态硬度指数(DSI)。此外,还使用超声波测量了踝关节背屈时腘静脉的峰值流速(PV)。每个参数都在 ASHIKA 长筒袜(AS)、与 AS 相同静态压力的 Mc(Mc1)和静态压力约为 Mc1 两倍的 Mc(Mc2)之间进行了比较。结果:SSI和DSI有明显差异,依次为AS < Mc1 < Mc2(P 结论:Mc1和Mc2的SSI和DSI有明显差异,依次为AS < Mc1 < Mc2(P 结论):明确了 Mc 的物理特征和压力特性。这种服装的高硬度提高了压力治疗的依从性,有助于慢性静脉功能不全的治疗。
{"title":"Development of a New Adjustable Compression Garment (McBoooon) Made of Non-Stretch Self-Adhesive Fabric.","authors":"Yasushi Shiraishi, Naomi Kinoto, Atsuko Miyoshi, Kyoko Ishii, Mika Ogawa","doi":"10.3400/avd.oa.23-00107","DOIUrl":"10.3400/avd.oa.23-00107","url":null,"abstract":"<p><p><b>Objectives:</b> To assess the physical features and compression characteristics of a newly developed adjustable compression garment, McBoooon (Mc). <b>Methods:</b> Twelve healthy volunteers were recruited to assess the compression characteristics. The interface pressure (IP) was continuously measured to calculate the static (SSI) and dynamic stiffness indices (DSI). Additionally, the peak flow velocity (PV) of the popliteal vein during ankle dorsiflexion was measured using ultrasonography. Each parameter was compared between ASHIKA stockings (AS), Mc applied at the same resting pressure as AS (Mc1), and Mc applied at a resting pressure approximately twice that of Mc1 (Mc2). <b>Results:</b> SSI and DSI were significantly different, increasing in the order AS < Mc1 < Mc2 (p <0.01). Although the PV was significantly higher in the compression group than in the control group (p <0.05), no significant differences were found among the three groups. <b>Conclusion:</b> The physical features and compression characteristics of Mc were clarified. The high stiffness of this garment improves the adherence to compression therapy and contributes to the treatment of chronic venous insufficiency.</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"17 2","pages":"164-170"},"PeriodicalIF":0.6,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11196178/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141449436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eicosapentaenoic Acid Level Predicts Long-Term Survival and Cardiovascular or Limb Event in Peripheral Arterial Disease. 二十碳五烯酸水平可预测外周动脉疾病患者的长期生存和心血管或肢体事件。
IF 0.6 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-06-25 Epub Date: 2024-03-08 DOI: 10.3400/avd.oa.23-00079
Hisao Kumakura, Ryuichi Funada, Yae Matsuo, Toshiya Iwasaki, Kuniki Nakashima, Eitoshi Tsuboi, Shuichi Ichikawa

Objectives: We examined the relationship between plasma eicosapentaenoic acid (EPA) level and long-term all-cause death (ACD) and cardiovascular or limb events in patients with peripheral arterial disease (PAD). Method: We performed a prospective cohort study on 637 PAD patients. The endpoints were ACD, major adverse cardiovascular events (MACEs), and lower extremity arterial events (LEAEs). Results: The incidences of ACD, MACEs, and LEAEs had correlation with EPA levels (p <0.05). Plasma EPA level had significant positive correlations with high-density lipoprotein cholesterol, triglyceride, and estimated glomerular filtration rate (eGFR), and negative correlation with C-reactive protein (CRP). In Cox stepwise multivariate analysis, lower EPA (hazard ratio [HR]: 0.996, 95% confidence interval [CI]: 0.993-1.000, p = 0.034), ankle brachial pressure index (ABI), body mass index, serum albumin, eGFR, age, CRP, D-dimer, critical limb ischemia, diabetes, cerebrovascular disease (CVD), and statin were related to ACD (p <0.05); lower EPA (HR: 0.997, 95% CI: 0.994-1.000, p = 0.038), ABI, serum albumin, eGFR, age, diabetes, coronary heart disease, CVD, and statin were related to MACEs (p <0.05); and lower EPA (HR: 0.988, 95% CI: 0.982-0.993, p <0.001), ABI, and low-density lipoprotein cholesterol were related to LEAEs (p <0.05). Conclusions: Low plasma EPA level was a significant risk factor for ACD, MACEs, and LEAEs in patients with PAD.

研究目的我们研究了外周动脉疾病(PAD)患者血浆二十碳五烯酸(EPA)水平与长期全因死亡(ACD)和心血管或肢体事件之间的关系。研究方法我们对 637 名 PAD 患者进行了前瞻性队列研究。研究终点为ACD、主要不良心血管事件(MACE)和下肢动脉事件(LEAE)。结果:ACD、MACEs 和 LEAEs 的发生率与 EPA 水平相关(p 结论:EPA 水平越低,ACD、MACEs 和 LEAEs 的发生率越高:血浆 EPA 水平低是 PAD 患者发生 ACD、MACE 和 LEAEs 的重要风险因素。
{"title":"Eicosapentaenoic Acid Level Predicts Long-Term Survival and Cardiovascular or Limb Event in Peripheral Arterial Disease.","authors":"Hisao Kumakura, Ryuichi Funada, Yae Matsuo, Toshiya Iwasaki, Kuniki Nakashima, Eitoshi Tsuboi, Shuichi Ichikawa","doi":"10.3400/avd.oa.23-00079","DOIUrl":"10.3400/avd.oa.23-00079","url":null,"abstract":"<p><p><b>Objectives:</b> We examined the relationship between plasma eicosapentaenoic acid (EPA) level and long-term all-cause death (ACD) and cardiovascular or limb events in patients with peripheral arterial disease (PAD). <b>Method:</b> We performed a prospective cohort study on 637 PAD patients. The endpoints were ACD, major adverse cardiovascular events (MACEs), and lower extremity arterial events (LEAEs). <b>Results:</b> The incidences of ACD, MACEs, and LEAEs had correlation with EPA levels (p <0.05). Plasma EPA level had significant positive correlations with high-density lipoprotein cholesterol, triglyceride, and estimated glomerular filtration rate (eGFR), and negative correlation with C-reactive protein (CRP). In Cox stepwise multivariate analysis, lower EPA (hazard ratio [HR]: 0.996, 95% confidence interval [CI]: 0.993-1.000, p = 0.034), ankle brachial pressure index (ABI), body mass index, serum albumin, eGFR, age, CRP, D-dimer, critical limb ischemia, diabetes, cerebrovascular disease (CVD), and statin were related to ACD (p <0.05); lower EPA (HR: 0.997, 95% CI: 0.994-1.000, p = 0.038), ABI, serum albumin, eGFR, age, diabetes, coronary heart disease, CVD, and statin were related to MACEs (p <0.05); and lower EPA (HR: 0.988, 95% CI: 0.982-0.993, p <0.001), ABI, and low-density lipoprotein cholesterol were related to LEAEs (p <0.05). <b>Conclusions:</b> Low plasma EPA level was a significant risk factor for ACD, MACEs, and LEAEs in patients with PAD.</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"17 2","pages":"135-141"},"PeriodicalIF":0.6,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11196169/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141449439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Subacute Limb Ischemia Suspected from COVID-19-Related Arterial Thrombosis Presenting with Local Occlusion Site Tenderness. 怀疑由 COVID-19 相关动脉血栓引起的亚急性肢体缺血,表现为局部闭塞部位触痛。
IF 0.6 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-06-25 Epub Date: 2024-04-10 DOI: 10.3400/avd.cr.23-00115
Kenshiroh Kawabe, Masamitsu Suhara, Ryosuke Taniguchi, Yasuaki Mochizuki, Toshio Takayama, Katsuyuki Hoshina

A 59-year-old man was admitted to our hospital with severe popliteal fossa pain and mild left calf claudication. He had had an episode of pyrexia and dyspnea approximately 3 weeks prior. Contrast-enhanced computed tomography revealed acute occlusion of the left popliteal artery and multiple infiltration shadows with bilateral multifocal parenchymal consolidation of the lungs, suggesting post-coronavirus disease 2019 (COVID-19) pneumonia. As he had no comorbid risk of cardiogenic embolism or atherosclerosis, we diagnosed him with COVID-19-related arterial thrombosis. COVID-19-related arterial thrombosis should be considered a possible cause of acute limb ischemia, even when ischemic symptoms occur several weeks post infection.

一名 59 岁的男子因腘窝剧痛和左小腿轻度跛行被送入我院。大约 3 周前,他曾出现过热病和呼吸困难。对比增强计算机断层扫描显示左侧腘动脉急性闭塞,肺部多发浸润阴影和双侧多灶性实质合并症,提示为2019年冠状病毒病(COVID-19)后肺炎。由于他没有合并心源性栓塞或动脉粥样硬化的风险,我们诊断他患有COVID-19相关动脉血栓。COVID-19相关动脉血栓应被视为急性肢体缺血的可能原因,即使缺血症状发生在感染后数周。
{"title":"Subacute Limb Ischemia Suspected from COVID-19-Related Arterial Thrombosis Presenting with Local Occlusion Site Tenderness.","authors":"Kenshiroh Kawabe, Masamitsu Suhara, Ryosuke Taniguchi, Yasuaki Mochizuki, Toshio Takayama, Katsuyuki Hoshina","doi":"10.3400/avd.cr.23-00115","DOIUrl":"10.3400/avd.cr.23-00115","url":null,"abstract":"<p><p>A 59-year-old man was admitted to our hospital with severe popliteal fossa pain and mild left calf claudication. He had had an episode of pyrexia and dyspnea approximately 3 weeks prior. Contrast-enhanced computed tomography revealed acute occlusion of the left popliteal artery and multiple infiltration shadows with bilateral multifocal parenchymal consolidation of the lungs, suggesting post-coronavirus disease 2019 (COVID-19) pneumonia. As he had no comorbid risk of cardiogenic embolism or atherosclerosis, we diagnosed him with COVID-19-related arterial thrombosis. COVID-19-related arterial thrombosis should be considered a possible cause of acute limb ischemia, even when ischemic symptoms occur several weeks post infection.</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"17 2","pages":"197-200"},"PeriodicalIF":0.6,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11196168/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141449443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Carotid Artery Reconstruction with an Autologous Bifurcated Saphenous Vein Graft. 用自体分叉隐静脉移植重建颈动脉
IF 0.6 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-06-25 Epub Date: 2024-03-15 DOI: 10.3400/avd.nmt.23-00118
Tomohiro Tsunekawa, Ryo Utakata, Yukiomi Fukumoto, Tomitaka Kubo, Fumiya Kuze

We present a new technique for carotid artery reconstruction using a modified bifurcated saphenous vein graft in a patient with a malignant neck tumor. This technique can optimize the size match between the SVG and common carotid artery, as well as the internal and external carotid arteries. Post operative computed tomography performed a year after the operation demonstrated excellent graft alignment and patent carotid arteries.

我们为颈部恶性肿瘤患者介绍了一种使用改良分叉大隐静脉移植物重建颈动脉的新技术。这种技术可以优化 SVG 和颈总动脉以及颈内动脉和颈外动脉之间的尺寸匹配。术后一年进行的计算机断层扫描显示,移植物排列整齐,颈动脉通畅。
{"title":"Carotid Artery Reconstruction with an Autologous Bifurcated Saphenous Vein Graft.","authors":"Tomohiro Tsunekawa, Ryo Utakata, Yukiomi Fukumoto, Tomitaka Kubo, Fumiya Kuze","doi":"10.3400/avd.nmt.23-00118","DOIUrl":"10.3400/avd.nmt.23-00118","url":null,"abstract":"<p><p>We present a new technique for carotid artery reconstruction using a modified bifurcated saphenous vein graft in a patient with a malignant neck tumor. This technique can optimize the size match between the SVG and common carotid artery, as well as the internal and external carotid arteries. Post operative computed tomography performed a year after the operation demonstrated excellent graft alignment and patent carotid arteries.</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"17 2","pages":"211-214"},"PeriodicalIF":0.6,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11196180/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141449398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnosis and Treatments of Limb Lymphedema: Review. 肢体淋巴水肿的诊断和治疗:回顾。
IF 0.6 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-06-25 Epub Date: 2024-03-13 DOI: 10.3400/avd.ra.24-00011
Shinya Kitayama

Lymphedema is caused by dysfunction of the lymphatic system. It is divided into primary edema with no apparent cause and secondary edema with an exogenous cause. The main symptoms are edema and heaviness, skin changes such as skin hardening, lymphocysts, lymphorrhoea, papillomas, and recurrent cellulitis. They are often irreversible and progressive, thus greatly reducing quality of life of the patients. Diagnosis is made by image examinations that can evaluate lymphatic flow and functions such as lymphoscintigraphy and indocyanine green fluorescence lymphangiography. Linear pattern and dermal backflow are the main findings. Conservative treatment consists of four components: compression therapy with elastic garments, exercise therapy, manual lymphatic drainage, and skin care, which is called complex physical therapy (CPT). Although CPT has become the gold standard of treatment, with evidence of efficacy reported in terms of volume reduction, maintenance, and prevention of cellulitis, it is a symptomatic treatment and does not improve impaired lymphatic flow. On the other hand, surgical treatment, such as lymphaticovenous anastomosis and vascularized lymph node transplantation, can create new lymphatic flow and improve lymphatic dysfunctions. Although these techniques are expected to be effective in volume reduction, cellulitis prevention, and improving quality of life, there is a need for more studies with a higher level of evidence in the future. In Japan, lymphedema is treated with a combination of conservative and surgical therapies, but lymphedema is intractable and few cases are completely cured. Therefore, how to improve the outcome of treatment is an important issue to be addressed in the future. (This is a translation of Jpn J Vasc Surg 2023; 32: 141-146.).

淋巴水肿是由淋巴系统功能障碍引起的。它分为无明显诱因的原发性水肿和有外源性诱因的继发性水肿。主要症状为水肿和沉重感、皮肤变化(如皮肤硬化)、淋巴囊肿、淋巴痔、乳头状瘤和复发性蜂窝组织炎。这些症状通常是不可逆和进行性的,因此大大降低了患者的生活质量。可通过淋巴管造影和吲哚菁绿荧光淋巴管造影等能评估淋巴流动和功能的图像检查来进行诊断。主要的检查结果是线性模式和真皮回流。保守治疗包括四个部分:弹力服加压疗法、运动疗法、人工淋巴引流和皮肤护理,即所谓的复合物理疗法(CPT)。虽然 CPT 已成为治疗的黄金标准,有证据表明它在减少蜂窝组织炎的体积、维持和预防方面具有疗效,但它只是一种对症治疗,并不能改善受损的淋巴流动。另一方面,手术治疗,如淋巴-静脉吻合术和血管淋巴结移植术,可以创造新的淋巴流动,改善淋巴功能障碍。虽然这些技术在减少淋巴体积、预防蜂窝组织炎和改善生活质量方面有望取得成效,但未来仍需要更多证据确凿的研究。在日本,淋巴水肿的治疗采用保守疗法和手术疗法相结合的方式,但淋巴水肿难以治愈,完全治愈的病例很少。因此,如何提高治疗效果是今后需要解决的重要问题。(本文译自《Jpn J Vasc Surg 2023; 32: 141-146》)。
{"title":"Diagnosis and Treatments of Limb Lymphedema: Review.","authors":"Shinya Kitayama","doi":"10.3400/avd.ra.24-00011","DOIUrl":"10.3400/avd.ra.24-00011","url":null,"abstract":"<p><p>Lymphedema is caused by dysfunction of the lymphatic system. It is divided into primary edema with no apparent cause and secondary edema with an exogenous cause. The main symptoms are edema and heaviness, skin changes such as skin hardening, lymphocysts, lymphorrhoea, papillomas, and recurrent cellulitis. They are often irreversible and progressive, thus greatly reducing quality of life of the patients. Diagnosis is made by image examinations that can evaluate lymphatic flow and functions such as lymphoscintigraphy and indocyanine green fluorescence lymphangiography. Linear pattern and dermal backflow are the main findings. Conservative treatment consists of four components: compression therapy with elastic garments, exercise therapy, manual lymphatic drainage, and skin care, which is called complex physical therapy (CPT). Although CPT has become the gold standard of treatment, with evidence of efficacy reported in terms of volume reduction, maintenance, and prevention of cellulitis, it is a symptomatic treatment and does not improve impaired lymphatic flow. On the other hand, surgical treatment, such as lymphaticovenous anastomosis and vascularized lymph node transplantation, can create new lymphatic flow and improve lymphatic dysfunctions. Although these techniques are expected to be effective in volume reduction, cellulitis prevention, and improving quality of life, there is a need for more studies with a higher level of evidence in the future. In Japan, lymphedema is treated with a combination of conservative and surgical therapies, but lymphedema is intractable and few cases are completely cured. Therefore, how to improve the outcome of treatment is an important issue to be addressed in the future. (This is a translation of Jpn J Vasc Surg 2023; 32: 141-146.).</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"17 2","pages":"114-119"},"PeriodicalIF":0.6,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11196164/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141449437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Distal Bypass Improves Skin Perfusion Pressure at the Whole Foot Regardless of Angiosomes in Patients with Chronic Limb-Threatening Ischemia. 远端分流术可改善慢性肢体缺血患者整个足部的皮肤灌注压,与血管瘤无关
IF 0.6 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-06-25 Epub Date: 2024-04-10 DOI: 10.3400/avd.oa.23-00105
Fukashi Serizawa, Yoshiyuki Nakano, Munetaka Hashimoto, Yoshihisa Tamate, Hiroko Sato, Masato Ohara, Keiichiro Kawamura, Daijiro Akamatsu, Takashi Kamei

Objectives: Distal bypass surgery's effect on tissue blood pressure beyond a focal angiosome remains debated. This study assessed tissue blood pressure in both direct revascularized angiosome (DRA) and indirect revascularized angiosome (IRA) after bypass surgery, utilizing repeated skin perfusion pressure (SPP) measurements. Methods: Twenty-nine limbs in 27 chronic limb-threatening ischemia (CLTI) patients (22 males and five females, age: 70.2 ± 9.3 years) who received distal bypass surgery were enrolled. SPP measurements were conducted for the DRA and IRA at 10 time intervals, encompassing both preoperative and postoperative periods of every 3-5 days until 30 days. Results: In total, 486 SPP measurements were collected from 58 measurement sites, and the transition of the SPP at the DRA was 35.4-62.5-59.5-70.2-58.2-62.2-63.1-63.6-63.8-73.4 mmHg and IRA was 29.4-53.4-53.7-58.8-51.3-63.1-47.9-62.1-57.6-61.0 mmHg. No significant differences were observed between SPP at the DRA and IRA. Fifteen wounds on the DRA (63%) and five on the IRA (100%) healed. Conclusion: Distal bypass improves SPP in both direct and IRAs of CLTI patients. These data indicated distal bypass improves tissue blood flow at entire foot regardless of angiosomes.

目的:远端搭桥手术对病灶血管外组织血压的影响仍存在争议。本研究通过重复测量皮肤灌注压 (SPP),评估搭桥手术后直接血管再通血管瘤 (DRA) 和间接血管再通血管瘤 (IRA) 的组织血压。方法:对 27 名接受远端搭桥手术的慢性肢体缺血(CLTI)患者(22 名男性和 5 名女性,年龄:70.2 ± 9.3 岁)的 29 个肢体进行了登记。在 10 个时间间隔内对 DRA 和 IRA 进行 SPP 测量,包括术前和术后,每 3-5 天测量一次,直至 30 天。结果:共从 58 个测量点采集了 486 次 SPP 测量值,DRA 的 SPP 过渡值为 35.4-62.5-59.5-70.2-58.2-62.2-63.1-63.6-63.8-73.4 mmHg,IRA 为 29.4-53.4-53.7-58.8-51.3-63.1-47.9-62.1-57.6-61.0 mmHg。DRA 和 IRA 的 SPP 没有明显差异。DRA 上的 15 个伤口(63%)和 IRA 上的 5 个伤口(100%)愈合。结论:远端分流术可改善 CLTI 患者直接和 IRA 的 SPP。这些数据表明,无论血管瘤的情况如何,远端分流术都能改善整个足部的组织血流。
{"title":"Distal Bypass Improves Skin Perfusion Pressure at the Whole Foot Regardless of Angiosomes in Patients with Chronic Limb-Threatening Ischemia.","authors":"Fukashi Serizawa, Yoshiyuki Nakano, Munetaka Hashimoto, Yoshihisa Tamate, Hiroko Sato, Masato Ohara, Keiichiro Kawamura, Daijiro Akamatsu, Takashi Kamei","doi":"10.3400/avd.oa.23-00105","DOIUrl":"10.3400/avd.oa.23-00105","url":null,"abstract":"<p><p><b>Objectives:</b> Distal bypass surgery's effect on tissue blood pressure beyond a focal angiosome remains debated. This study assessed tissue blood pressure in both direct revascularized angiosome (DRA) and indirect revascularized angiosome (IRA) after bypass surgery, utilizing repeated skin perfusion pressure (SPP) measurements. <b>Methods:</b> Twenty-nine limbs in 27 chronic limb-threatening ischemia (CLTI) patients (22 males and five females, age: 70.2 ± 9.3 years) who received distal bypass surgery were enrolled. SPP measurements were conducted for the DRA and IRA at 10 time intervals, encompassing both preoperative and postoperative periods of every 3-5 days until 30 days. <b>Results:</b> In total, 486 SPP measurements were collected from 58 measurement sites, and the transition of the SPP at the DRA was 35.4-62.5-59.5-70.2-58.2-62.2-63.1-63.6-63.8-73.4 mmHg and IRA was 29.4-53.4-53.7-58.8-51.3-63.1-47.9-62.1-57.6-61.0 mmHg. No significant differences were observed between SPP at the DRA and IRA. Fifteen wounds on the DRA (63%) and five on the IRA (100%) healed. <b>Conclusion:</b> Distal bypass improves SPP in both direct and IRAs of CLTI patients. These data indicated distal bypass improves tissue blood flow at entire foot regardless of angiosomes.</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"17 2","pages":"150-156"},"PeriodicalIF":0.6,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11196174/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141449438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interventions in Acute or Subacute Phase for Type B Aortic Dissection. B 型主动脉夹层急性期或亚急性期的干预措施。
IF 0.6 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-06-25 Epub Date: 2024-03-26 DOI: 10.3400/avd.ra.24-00012
Masaaki Kato

The treatment strategy for acute and subacute Stanford type B aortic dissection has changed significantly since the advent of thoracic endovascular aortic repair (TEVAR). Indication for invasive treatment: In addition to the conventional complicated cases (rupture or malperfusion case), the indication for invasive treatment now includes cases with refractory hypertension, persistent or recurrent pain, large aortic diameter, and other conditions that are considered to have a poor prognosis with conservative treatment. Treatment methods: TEVAR is the first choice for acute, subacute, and early chronic-stage treatment, and when this is not possible, other techniques (fenestration and graft replacement) are chosen. Treatment timing: The timing of invasive treatment should be emergent in life-threatening conditions (for rupture or malperfusion case) and immediate in symptomatic cases, while in other cases, preemptive TEVAR is considered appropriate on a scheduled timing within 6 months of onset. (This is a translation of Jpn J Vasc Surg 2023; 32: 157-163.).

自从胸腔内主动脉血管修复术(TEVAR)问世以来,急性和亚急性斯坦福B型主动脉夹层的治疗策略发生了重大变化。有创治疗的适应症:除了传统的复杂病例(破裂或灌注不良病例)外,现在有创治疗的适应症还包括难治性高血压、持续或反复疼痛、主动脉直径过大以及其他保守治疗预后不良的病例。治疗方法:TEVAR 是急性期、亚急性期和早期慢性期治疗的首选,如果无法进行 TEVAR 治疗,则选择其他技术(瓣膜置换术和移植物置换术)。治疗时机:对于危及生命的病例(破裂或灌注不良病例),应立即进行有创治疗;对于无症状病例,应立即进行有创治疗;而对于其他病例,则应在发病后 6 个月内按计划进行先期 TEVAR。(本文译自《Jpn J Vasc Surg 2023; 32: 157-163》)。
{"title":"Interventions in Acute or Subacute Phase for Type B Aortic Dissection.","authors":"Masaaki Kato","doi":"10.3400/avd.ra.24-00012","DOIUrl":"10.3400/avd.ra.24-00012","url":null,"abstract":"<p><p>The treatment strategy for acute and subacute Stanford type B aortic dissection has changed significantly since the advent of thoracic endovascular aortic repair (TEVAR). Indication for invasive treatment: In addition to the conventional complicated cases (rupture or malperfusion case), the indication for invasive treatment now includes cases with refractory hypertension, persistent or recurrent pain, large aortic diameter, and other conditions that are considered to have a poor prognosis with conservative treatment. Treatment methods: TEVAR is the first choice for acute, subacute, and early chronic-stage treatment, and when this is not possible, other techniques (fenestration and graft replacement) are chosen. Treatment timing: The timing of invasive treatment should be emergent in life-threatening conditions (for rupture or malperfusion case) and immediate in symptomatic cases, while in other cases, preemptive TEVAR is considered appropriate on a scheduled timing within 6 months of onset. (This is a translation of Jpn J Vasc Surg 2023; 32: 157-163.).</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"17 2","pages":"120-127"},"PeriodicalIF":0.6,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11196166/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141452722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Absolute Lymphocyte Count Predicts Bypass Surgery Outcomes in Patients with Chronic Limb-Threatening Ischemia. 绝对淋巴细胞计数可预测慢性肢体缺血患者的搭桥手术效果。
IF 0.6 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-06-25 Epub Date: 2024-04-10 DOI: 10.3400/avd.oa.23-00088
Satoshi Yamamoto, Takuya Hashimoto, Masaya Sano, Masaru Kimura, Osamu Sato, Juno Deguchi

Objectives: The aim of this study was to evaluate the relationship between absolute lymphocyte count (ALC) and outcomes of infrainguinal bypass surgery for chronic limb-threatening ischemia (CLTI). Methods: From 2004 to 2020, 209 limbs of 189 patients who underwent infrainguinal bypass surgery for CLTI and whose ALCs were available were included. Patients with survival >2 years and limb salvage >2 years were considered discriminant groups, and an ALC cut-off value was calculated. The relationship between preoperative ALC and outcomes was evaluated. Results: Survivorship of the higher ALC group was significantly higher than that of the lower ALC group (cut-off value 1030/μL, p = 0.0009). The limb salvage rate of the higher ALC group was significantly higher than that of the lower ALC group (cut-off value 1260/μL, p = 0.0081). In the dialysis patient group (103 limbs), the limb salvage rate of the higher ALC group was significantly higher than that of the lower ALC group (cut-off value 1170/μL, p = 0.026). ALC was independently associated with limb loss in multivariate analysis. Conclusion: ALC is promising as a predictor of outcomes after bypass surgery in CLTI. In particular, ALC is expected to be useful for limb prognosis in hemodialysis patients.

研究目的本研究旨在评估绝对淋巴细胞计数(ALC)与慢性肢体缺血(CLTI)腹股沟下搭桥手术疗效之间的关系。研究方法从 2004 年到 2020 年,共纳入了 189 名接受腹股沟下搭桥手术治疗慢性肢体缺血(CLTI)的患者的 209 条肢体,这些患者的 ALC 均可获得。将存活期大于 2 年和肢体挽回期大于 2 年的患者视为判别组,并计算出 ALC 临界值。评估了术前 ALC 与预后之间的关系。结果:高ALC组的生存率明显高于低ALC组(临界值为1030/μL,P = 0.0009)。高ALC组的肢体挽救率明显高于低ALC组(临界值为1260/μL,P = 0.0081)。在透析患者组(103 个肢体)中,ALC 较高组的肢体挽救率明显高于 ALC 较低组(临界值为 1170/μL,p = 0.026)。在多变量分析中,ALC与肢体缺失独立相关。结论:ALCALC有望预测CLTI患者搭桥手术后的预后。尤其是,ALC有望用于血液透析患者的肢体预后。
{"title":"Absolute Lymphocyte Count Predicts Bypass Surgery Outcomes in Patients with Chronic Limb-Threatening Ischemia.","authors":"Satoshi Yamamoto, Takuya Hashimoto, Masaya Sano, Masaru Kimura, Osamu Sato, Juno Deguchi","doi":"10.3400/avd.oa.23-00088","DOIUrl":"10.3400/avd.oa.23-00088","url":null,"abstract":"<p><p><b>Objectives</b>: The aim of this study was to evaluate the relationship between absolute lymphocyte count (ALC) and outcomes of infrainguinal bypass surgery for chronic limb-threatening ischemia (CLTI). <b>Methods</b>: From 2004 to 2020, 209 limbs of 189 patients who underwent infrainguinal bypass surgery for CLTI and whose ALCs were available were included. Patients with survival >2 years and limb salvage >2 years were considered discriminant groups, and an ALC cut-off value was calculated. The relationship between preoperative ALC and outcomes was evaluated. <b>Results</b>: Survivorship of the higher ALC group was significantly higher than that of the lower ALC group (cut-off value 1030/μL, p = 0.0009). The limb salvage rate of the higher ALC group was significantly higher than that of the lower ALC group (cut-off value 1260/μL, p = 0.0081). In the dialysis patient group (103 limbs), the limb salvage rate of the higher ALC group was significantly higher than that of the lower ALC group (cut-off value 1170/μL, p = 0.026). ALC was independently associated with limb loss in multivariate analysis. <b>Conclusion</b>: ALC is promising as a predictor of outcomes after bypass surgery in CLTI. In particular, ALC is expected to be useful for limb prognosis in hemodialysis patients.</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"17 2","pages":"142-149"},"PeriodicalIF":0.6,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11196179/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141449397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serious Adverse Events with Cyanoacrylate Closure of Varicose Veins: An Initial Report from a Large-Scale National Survey in Japan. 氰基丙烯酸酯封闭静脉曲张的严重不良事件:日本大规模全国调查的初步报告。
IF 0.8 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-03-25 Epub Date: 2023-12-08 DOI: 10.3400/avd.oa.23-00106
Michihisa Umetsu, Masayuki Hirokawa, Eri Fukaya, Eiichi Teshima, Hitoshi Kusagawa, Toshiya Nishibe, Hiroko Nemoto, Makoto Mo, Tomohiro Ogawa

Objective: Cyanoacrylate closure (CAC) is a minimally invasive technique for the treatment of varicose veins. A recent paper reported serious adverse events (AEs) associated with this use. This triggered an urgent survey to determine the incidence of AEs in Japan. Methods: The CAC-AE survey was sent to all 1,030 institutions authorized for CAC treatments. Cases performed between January 2020 and October 2023 were surveyed. Data on serious AEs and mortality were collected. Results: There were 623 surveys returned. There were 16 cases of proximal deep vein thrombosis, 3 cases of pulmonary embolism (PE), and 0 cases of stroke. Deep vein occlusion due to cyanoacrylate extension was observed in 1 case. Vein resection due to infection was observed in 4 cases. There were 299 cases of localized phlebitis and/or allergic reactions requiring steroid administration. Systemic allergic reactions requiring steroid administration were observed in 66 cases. There was no anaphylaxis associated with cyanoacrylate. There was one postoperative death from PE. Conclusion: This report's intent is to provide real world data on serious AEs following CAC from Japan given current concern over these events. An extensive report investigation of individual complications with analysis including causality will be provided following a full investigation separately.

目的:氰基丙烯酸酯闭合术(CAC)是一种治疗静脉曲张的微创技术。最近的一篇论文报道了与该技术相关的严重不良事件(AEs)。这引发了一项紧急调查,以确定 AEs 在日本的发生率。调查方法向所有获得 CAC 治疗授权的 1030 家机构发送 CAC-AE 调查表。调查对象为 2020 年 1 月至 2023 年 10 月期间接受治疗的病例。收集了有关严重 AE 和死亡率的数据。结果:共收回 623 份调查问卷。其中近端深静脉血栓形成 16 例,肺栓塞(PE)3 例,中风 0 例。观察到 1 例因氰基丙烯酸酯延伸导致的深静脉闭塞。4例因感染导致静脉切除。有 299 例出现局部静脉炎和/或过敏反应,需要使用类固醇。需要使用类固醇的全身过敏反应有 66 例。没有出现与氰基丙烯酸酯相关的过敏性休克。有 1 例因 PE 术后死亡。结论:鉴于目前对 CAC 严重并发症的关注,本报告旨在提供日本 CAC 术后严重并发症的真实数据。在进行全面调查后,将另行提供对个别并发症的广泛调查报告和包括因果关系在内的分析。
{"title":"Serious Adverse Events with Cyanoacrylate Closure of Varicose Veins: An Initial Report from a Large-Scale National Survey in Japan.","authors":"Michihisa Umetsu, Masayuki Hirokawa, Eri Fukaya, Eiichi Teshima, Hitoshi Kusagawa, Toshiya Nishibe, Hiroko Nemoto, Makoto Mo, Tomohiro Ogawa","doi":"10.3400/avd.oa.23-00106","DOIUrl":"10.3400/avd.oa.23-00106","url":null,"abstract":"<p><p><b>Objective:</b> Cyanoacrylate closure (CAC) is a minimally invasive technique for the treatment of varicose veins. A recent paper reported serious adverse events (AEs) associated with this use. This triggered an urgent survey to determine the incidence of AEs in Japan. <b>Methods:</b> The CAC-AE survey was sent to all 1,030 institutions authorized for CAC treatments. Cases performed between January 2020 and October 2023 were surveyed. Data on serious AEs and mortality were collected. <b>Results:</b> There were 623 surveys returned. There were 16 cases of proximal deep vein thrombosis, 3 cases of pulmonary embolism (PE), and 0 cases of stroke. Deep vein occlusion due to cyanoacrylate extension was observed in 1 case. Vein resection due to infection was observed in 4 cases. There were 299 cases of localized phlebitis and/or allergic reactions requiring steroid administration. Systemic allergic reactions requiring steroid administration were observed in 66 cases. There was no anaphylaxis associated with cyanoacrylate. There was one postoperative death from PE. <b>Conclusion:</b> This report's intent is to provide real world data on serious AEs following CAC from Japan given current concern over these events. An extensive report investigation of individual complications with analysis including causality will be provided following a full investigation separately.</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"17 1","pages":"21-24"},"PeriodicalIF":0.8,"publicationDate":"2024-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11018107/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140846904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of vascular diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1